Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 36-41

  Poleni, Paul Emile ^a   Akieda Asai, Sayaka ^a   Koda, Shuichi ^b   Sakurai, Maya ^a   Bae, Cho Rong ^c   Senba, Kazuyo ^a   Cha, Youn Soo ^c   Furuya, Mayumi ^b   Date, Yukari ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c Chonbuk National University   (South Korea)

Author keywords

AMPK; Feeding; GLP 1; Leptin; MC4 R

Indexed keywords

AGOUTI RELATED PEPTIDE; ALPHA MELANOCORTIN STIMULATING HORMONE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PROOPIOMELANOCORTIN; PROTEIN INHIBITOR; RECOMBINANT LEPTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDING BEHAVIOR; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ALPHA-MSH; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DRUG INTERACTIONS; EATING; FEEDING BEHAVIOR; GLUCAGON-LIKE PEPTIDE 1; LEPTIN; MALE; MELANOCYTE-STIMULATING HORMONES; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4;

AGOUTI; RATTUS;

EID: 84859104548     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.109     Document Type: Article

References (35)

1. Bray G.A. Weight homeostasis. Annu. Rev. Med. 1991, 42:205-216.
2. Keesey R.E., Hirvonen M.D. Body weight set-points: determination and adjustment. J. Nutr. 1997, 127:1875S-1883S.
3. Havel P.J. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp. Biol. Med. 2001, 226:963-977.
4. Cummings D.E., Schwartz M.W. Genetics and pathophysiology of human obesity. Annu. Rev. Med. 2003, 54:453-471.
5. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 1999, 20:68-100.
6. Emond M., Schwartz G.J., Ladenheim E.E., Moran T.H. Central leptin modulates behavioral and neural responsivity to CCK. Am. J. Physiol. 1999, 276:R1545-R1549.
7. Ladenheim E.E., Emond M., Moran T.H. Leptin enhances feeding suppression and neural activation produced by systemically administered bombesin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R473-R477.
8. Turek V.F., Trevaskis J.L., Levin B.E., Dunn-Meynell A.A., Irani B., Gu G., Wittmer C., Griffin P.S., Vu C., Parkes D.G., Roth J.D. Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 2010, 151:143-152.
9. Williams D.L., Baskin D.G., Schwartz M.W. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006, 55:3387-3393.
10. Mojsov S., Heinrich G., Wilson I.B., Ravazzola M., Orci L., Habener J.F. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J. Biol. Chem. 1986, 261:11880-11889.
11. Hayes M.R., De Jonghe B.C., Kanoski S.E. Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol. Behav. 2010, 100:503-510.
12. Holst J.J. The physiology of glucagon-like peptide 1. Physiol. Rev. 2007, 87:1409-1439.
13. Rossi M., Kim M.S., Morgan D.G., Small C.J., Edwards C.M., Sunter D., Abusnana S., Goldstone A.P., Russell S.H., Stanley S.A., Smith D.M., Yagaloff K., Ghatei M.A., Bloom S.R. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 1998, 139:4428-4431.
14. Edwards C.M., Abbott C.R., Sunter D., Kim M., Dakin C.L., Murphy K.G., Abusnana S., Taheri S., Rossi M., Bloom S.R. Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat. Brain Res. 2000, 866:128-134.
15. Date Y., Mondal M.S., Kageyama H., Ghamari-Langroudi M., Takenoya F., Yamaguchi H., Shimomura Y., Mori M., Murakami N., Shioda S., Cone R.D., Nakazato M. Neuropeptide W: an anorectic peptide regulated by leptin and metabolic state. Endocrinology 2010, 151:2200-2210.
16. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 2002, 122:531-544.
17. Fehmann H.C., Göke R., Göke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 1995, 16:390-410.
18. Nonaka K., Kakikawa T., Sato A., Okuyama K., Fujimoto G., Kato N., Suzuki H., Hirayama Y., Ahmed T., Davies M.J., Stein P.P. Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Res. Clin. Pract. 2008, 7:291-298.
19. Kikuchi M., Abe N., Kato M., Terao S., Mimori N., Tachibana H. Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 2009, 83:233-240.
20. Seino Y., Rasmussen M.F., Zdravkovic M., Kaku K. Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: a double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes. Diabetes Res. Clin. Pract. 2008, 81:161-168.
21. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
22. Tang-Christensen M., Larsen P.J., Göke R., Fink-Jensen A., Jessop D.S., Møller M., Sheikh S.P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am. J. Physiol. 1996, 271:R848-856.
23. Navarro M., Rodriquez de Fonseca F., Alvarez E., Chowen J.A., Zueco J.A., Gomez R., Eng J., Blázquez E. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J. Neurochem. 1996, 67:1982-1991.
24. Szayna M., Doyle M.E., Betkey J.A., Holloway H.W., Spencer R.G., Greig N.H., Egan J.M. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 2000, 141:1936-1941.
25. Rodriquez de Fonseca F., Navarro M., Alvarez E., Roncero I., Chowen J.A., Maestre O., Gómez R., Muñoz R.M., Eng J., Blázquez E. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 2000, 49:709-717.
26. Patterson C.M., Bouret S.G., Dunn-Meynell A.A., Levin B.E. Three weeks of postweaning exercise in DIO rats produces prolonged increases in central leptin sensitivity and signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R537-R548.
27. Rüttimann E.B., Arnold M., Hillebrand J.J., Geary N., Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009, 150:1174-1181.
28. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
29. Ramamurthy S., Ronnett G.V. Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J. Physiol. 2006, 574:85-93.
30. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferré P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
31. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 2004, 279:12005-12008.
32. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., Yun J.Y., Namgoong I.S., Ha J., Park I.S., Lee I.K., Viollet B., Youn J.H., Lee H.K., Lee K.U. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 2004, 10:727-733.
33. Seo S., Ju S., Chung H., Lee D., Park S. Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats. Endocr. J. 2008, 55:867-874.
34. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:31-141.
35. Minokoshi Y., Shiuchi T., Lee S., Suzuki A., Okamoto S. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition 2008, 24:786-790.